Sanam Loghavi MD

PubMed

• 1 citations
  Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.
  Jayastu Senapati, Sanam Loghavi, Jennifer Marvin-Peek, Guillermo Garcia-Manero, Tapan M Kadia
  American Journal of Hematology. 2025-05-01
• Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasms.
  Kelly S Chien, Julie S Braish, Ziyi Li, Sanam Loghavi, Alex Bataller
  Leukemia. 2025-04-02
• Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review.
  Karen Amelia Nahmod, Roberto N Miranda, Francisco Vega, Beenu Thakral, Naveen Pemmaraju
  Leukemia & Lymphoma. 2025-04-01

Journal Articles

• Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
  Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood

Abstracts/Posters

• Higher Stability of Mutant IDH1/2 mRNA As Compared to Wild-Type mRNA in Patients with Acute Myeloid Leukemia
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Early Achievement of Measurable Residual Disease Negativity in the Treatment of Adults with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia Is a Strong P...
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase II Randomized Trial of Gilteritinib Vs Midostaurin in Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML)
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics ...
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Preliminary Results from the Phase II Study of the IDH2-Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS)
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Expression Profiling of mRNA By Next Generation Sequencing and the Development of Algorithm for Predicting Response in Acute Myeloid Leukemia
  Sanam Loghavi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Five-Day Versus Ten-Day Schedules of Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase II Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018